Clover Health Investments (CLOV) shares rose 8% on Thursday after Deutsche Bank initiated coverage of the stock with a buy rating and a price target of $6 per share.
Trading volume stood at nearly 5.1 million shares compared with a daily average of close to 5.4 million shares.
Price: $4.69, Change: $+0.35, Percent Change: +7.95%